GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

MDXG · Sep 30, 2024

MIMEDX GROUP, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001376339-24-000065General Corporate

Debt relative to revenueRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.debt_to_revenue

22.63% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

23.35% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

2.87% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

28.85% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

81.77% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

13.28% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

3.47% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

4.53% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesHistory building

Jun 30, 20230/7 normalizedLevel 3 Sep 30, 20230/7 normalizedLevel 3 Dec 31, 20230/8 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/8 normalizedLevel 3 Sep 30, 20240/8 normalizedLevel 3 Dec 31, 20240/8 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20256/8 normalizedLevel 3 Sep 30, 20256/8 normalizedLevel 3 Dec 31, 20257/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3 Jun 30, 20268/8 normalizedLevel 3

Period transition

What moved in the state?

Balance Sheet Leverage Increased

Previous: 22.07%
Current: 22.63%
Delta: 0.55%

Cash Generation Decreased

Previous: 25.01%
Current: 23.35%
Delta: -1.67%

Growth Decreased

Previous: 7.32%
Current: 2.87%
Delta: -4.45%

Inventory Pressure Increased

Previous: 28.73%
Current: 28.85%
Delta: 0.12%

Margin Decreased

Previous: 82.97%
Current: 81.77%
Delta: -1.19%

Profitability Decreased

Previous: 26.89%
Current: 13.28%
Delta: -13.61%

R And D Intensity Increased

Previous: 3.45%
Current: 3.47%
Delta: 0.02%

Sbc Intensity Decreased

Previous: 4.69%
Current: 4.53%
Delta: -0.16%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · MDXG Fundamental State →Has State · MIMEDX GROUP, INC. →Transitioned To · MDXG Fundamental State →Transitioned To · MDXG BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · MDXG CASH_GENERATION_DECREASED →Transitioned To · MDXG GROWTH_DECREASED →Transitioned To · MDXG INVENTORY_PRESSURE_INCREASED →Transitioned To · MDXG MARGIN_DECREASED →Transitioned To · MDXG PROFITABILITY_DECREASED →Transitioned To · MDXG R_AND_D_INTENSITY_INCREASED →Transitioned To · MDXG SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.